Viridian Therapeutics, Inc.\DE

By person

23 insiders · 71 transactions

1.1×

Stephen Mahoney holds only 1.1 times base salary in stock. $811.69K of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Stephen Mahoney last reported holding, valued at $24.50, the price Common Stock was last bought or sold at on the open market here, on 19 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fairmount Funds Management LLC entity

Director

$90.00M (6)

—

+$90.00M

5,617,321

4.96%

$137.62M

+15,907%

Violin Jonathan

Chief Executive Officer

—

$4.27M (10)

−$4.27M

430,905

0.3803%

$10.56M

—

Katz Barrett

Chief Medical Officer

—

$3.17M (4) scheduled

−$3.17M

0.0000%

$0.00

—

Booth Bruce

Director

$3.00M (1)

—

+$3.00M

3,142,580

2.77%

$76.99M

+21.0%

Meisner Lara

Chief Legal Officer

—

$2.54M (14) scheduled

−$2.54M

29,971

0.0265%

$734.29K

−50.0%

Logos Global Master Fund LP entity

10% owner

$2.27M (3)

—

+$2.27M

550,000

0.4855%

$13.48M

+650.0%

Frazier Life Sciences Public Fund, L.P. entity

10% owner

$2.20M (1)

—

+$2.20M

1,505,200

1.33%

$36.88M

+15.3%

LEFKOFF KYLE

Director

—

$540.14K (10)

−$540.14K

463,473

0.4091%

$11.36M

−7.4%

Mahoney Stephen F.

President and CEO

$499.26K (1)

—

+$499.26K

33,130

0.0292%

$811.69K

+3,213%

Tousignant Jennifer

Chief Legal Officer

—

$418.99K (3) scheduled

−$418.99K

0.0000%

$0.00

−100.0%

Myers Scott Dunseth

Chief Executive Officer

$261.80K (2)

—

+$261.80K

259,500

0.2291%

$6.36M

—

Beetham Thomas W.

Chief Operating Officer

$117.05K (1)

—

+$117.05K

13,271

0.0117%

$325.14K

+563.6%

Levy Adam Scott

Chief Business Officer

$51.51K (2)

—

+$51.51K

13,040

0.0115%

$319.48K

+247.7%

Hughes Thomas E.

Director

$47.70K (1)

$96.00K (1)

−$48.30K

12,827

0.0113%

$314.26K

−8.7%

Riccitelli Samuel D

President & CEO

—

571,370

0.5043%

$14.00M

+20.4%

LEBOW BENNETT S

Director

—

429,441

0.3791%

$10.52M

+187.9%

Marshall William Stuart

See Remarks

—

273,146

0.2411%

$6.69M

+73.6%

FAVORITO TAMARA A

CFO, Secretary, Treasurer

—

106,447

0.0940%

$2.61M

+294.3%

Leverone Jason A.

Chief Financial Officer

—

48,829

0.0431%

$1.20M

+885.1%

Tripuraneni Radhika

Chief Medical Officer

—

40,000

0.0353%

$980.00K

—

Harmon Seth

Chief Financial Officer

—

7,790

0.0069%

$190.86K

+115.6%

Smith Robin L

Director

—

1,900

0.0017%

$46.55K

+171.4%

Gonyer David A

Director

—

1,899

0.0017%

$46.53K

+171.7%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Tousignant Jennifer

31 Dec 2025

Chief Legal Officer

Sell

2,272

$31.16

$70.80K

Meisner Lara

9 Mar 2023

General Counsel and Secretary

Sell

29,971

$29.07

$871.26K

Violin Jonathan

2 Feb 2023

Chief Executive Officer

Sell

50,000

$36.80

$1.84M

Violin Jonathan

1 Jun 2022

Chief Executive Officer

Sell

30,000

$12.20

$366.00K

Violin Jonathan

2 May 2022

Chief Executive Officer

Sell

30,000

$13.04

$391.20K

Violin Jonathan

4 Apr 2022

Chief Executive Officer

Sell

3,600

$18.93

$68.15K

Violin Jonathan

1 Apr 2022

Chief Executive Officer

Sell

26,400

$18.92

$499.49K

Violin Jonathan

2 Mar 2022

Chief Executive Officer

Sell

11,106

$17.36

$192.80K

Violin Jonathan

1 Mar 2022

Chief Executive Officer

Sell

18,894

$17.82

$336.69K

Violin Jonathan

3 Feb 2022

Chief Executive Officer

Sell

909

$19.16

$17.42K

Violin Jonathan

2 Feb 2022

Chief Executive Officer

Sell

12,340

$18.47

$227.92K

Violin Jonathan

1 Feb 2022

Chief Executive Officer

Sell

16,751

$19.55

$327.48K

Hughes Thomas E.

20 Dec 2017

Director

Sell

12,000

$8.00

$96.00K

LEFKOFF KYLE

10 Mar 2017

Director

Sell indirect

3,300

$14.31

$47.23K

LEFKOFF KYLE

9 Mar 2017

Director

Sell indirect

2,500

$14.38

$35.96K

LEFKOFF KYLE

8 Mar 2017

Director

Sell indirect

5,000

$14.70

$73.51K

LEFKOFF KYLE

6 Mar 2017

Director

Sell indirect

608

$16.24

$9.87K

LEFKOFF KYLE

6 Mar 2017

Director

Sell indirect

9,392

$15.71

$147.59K

LEFKOFF KYLE

28 Feb 2017

Director

Sell indirect

2,258

$13.54

$30.58K

LEFKOFF KYLE

27 Feb 2017

Director

Sell indirect

1,500

$13.79

$20.69K

LEFKOFF KYLE

24 Feb 2017

Director

Sell indirect

6,500

$14.04

$91.25K

LEFKOFF KYLE

23 Feb 2017

Director

Sell indirect

1,800

$13.65

$24.57K

LEFKOFF KYLE

22 Feb 2017

Director

Sell indirect

4,102

$14.36

$58.89K

Show all 71 transactions →

Viridian Therapeutics, Inc.\DE

By person

Individual transactions

What was left out